Cui et al. (2022) demonstrated that, following CIS treatment, rat ovarian tissue exhibited increased expression of fibrosis-related markers, such as Col-I, Col-III, fibronectin, connective tissue growth factor (CTGF), and alpha-smooth muscle actin (α-SMA) (Cui et al., 2022). This evidence concerns the gene CCN2 and in situ carcinoma.